secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-02-25T23:59:59+00:00
Accession:  0000896264-25-000054
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q4 net sales -3% to $214M; net earnings -73% to $4.5M; FY2025 guidance includes Hiya
--------------------------------------------------------------------------------

- Q4 net sales $214M (-3% YoY); net earnings $4.5M (-73%); diluted EPS $0.23 (-74%).
- FY2024 net sales $855M (-7% YoY); net earnings $42M (-34%); diluted EPS $2.19.
- Active customers 454K (-6% YoY); Americas & Europe net sales +1% YoY, Asia Pacific -6%.
- Closed acquisition of 78.8% of Hiya on Dec 23, 2024; contributed ~$2M in Q4 sales.
- FY2025 outlook: net sales $920M–$1.0B; diluted EPS $1.50–$2.20; adjusted diluted EPS $2.35–$3.00.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000054/0000896264-25-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000054/usna-20250225.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer